Detalhe da pesquisa
1.
Pediatric Donor Cell Acute Lymphoblastic Leukemia Following Bone Marrow Transplant for GATA2 Mutation.
J Pediatr Hematol Oncol
; 44(5): 268-270, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35235548
2.
Chimeric antigen receptor T-cell therapy for marrow and extramedullary relapse of infant acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 68(1): e28739, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33009894
3.
Systemic Lupus Erythematosus, Evans Syndrome, and Neurofibromatosis: An Unusual Combination in Pediatric Patient.
J Pediatr Hematol Oncol
; 42(4): e244-e247, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31033790
4.
Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia.
Blood
; 138(21): 2138-2142, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34499715
5.
INSPIRED Symposium Part 5: Expanding the Use of CAR T Cells in Children and Young Adults.
Transplant Cell Ther
; 2024 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588880
6.
Practice Preferences for Consolidative Hematopoietic Stem Cell Transplantation Following Tisagenlecleucel in Children and Young Adults with B Cell Acute Lymphoblastic Leukemia.
Transplant Cell Ther
; 30(1): 75.e1-75.e11, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37816472
7.
INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia.
Transplant Cell Ther
; 29(11): 674-684, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37689393
8.
SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report.
J Immunother Cancer
; 11(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36707090
9.
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns.
EClinicalMedicine
; 65: 102268, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37954907
10.
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia.
J Clin Oncol
; 41(2): 354-363, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108252
11.
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL.
Blood Adv
; 7(12): 2758-2771, 2023 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36857419
12.
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium.
Blood Adv
; 7(4): 541-548, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35938863
13.
Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research.
Transplant Cell Ther
; 29(6): 346.e1-346.e10, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36924931
14.
Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy.
Blood Adv
; 6(7): 1961-1968, 2022 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34788386
15.
Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report.
Blood Adv
; 6(2): 600-610, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794180
16.
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report.
J Clin Oncol
; 40(9): 945-955, 2022 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34882493
17.
Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes.
Transplant Cell Ther
; 28(7): 409.e1-409.e10, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35447374
18.
Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia.
Blood Adv
; 6(14): 4251-4255, 2022 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35580324
19.
Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma.
Blood Adv
; 4(21): 5414-5424, 2020 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33147337
20.
Introduction to the Reports from the Insights in Pediatric CAR T-cell Immunotherapy: Recent Advances and Future Directions (INSPIRED) Symposium.
Transplant Cell Ther
; 29(10): 592-593, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37442348